Zhejiang Hisoar Pharmaceutical Co (SZSE:002099) Net Issuance of Debt : ¥158 Mil (TTM As of Mar. 2025)

View and export this data going back to 2006. Start your Free Trial

What is Zhejiang Hisoar Pharmaceutical Co Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Zhejiang Hisoar Pharmaceutical Co's net issuance of debt for the three months ended in Mar. 2025 was ¥290 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2025 was ¥158 Mil.

Zhejiang Hisoar Pharmaceutical Co Net Issuance of Debt Historical Data

The historical data trend for Zhejiang Hisoar Pharmaceutical Co's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Hisoar Pharmaceutical Co Net Issuance of Debt Chart

Zhejiang Hisoar Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Debt

Get a 7-Day Free Trial

230.00

140.00

411.16

57.44

183.00

Zhejiang Hisoar Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Debt	Get a 7-Day Free Trial															314.90	-128.40	-120.40	116.90	290.04

Zhejiang Hisoar Pharmaceutical Co Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥158 Mil.

Zhejiang Hisoar Pharmaceutical Co Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Zhejiang Hisoar Pharmaceutical Co's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Hisoar Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) » Definitions » Net Issuance of Debt

Traded in Other Exchanges

N/A

Address

No. 507 Shifu Avenue, Taizhou International Business Plaza, Block A, 8F, Taizhou, Zhejiang, CHN, 318000

Website

http://www.hisoar.com

Zhejiang Hisoar Pharmaceutical Co Ltd is a China-based company engages in the production of specialty raw materials, preparations and fine chemicals, dyes and dye intermediates. Its products include Clindamycin hydrochloride, Clindamycin phosphate, Florfenicol, Atova, Thiamphenicol, and Riglinay.

Executives

Wang Yang Chao	Director
Yang Si Wei	Directors, executives
Xu Guo Rui	Executives
Xu Hua Qing	Secretary Dong
Hong Ming	Director
Guo Min Long	Director
Li Hong Ming	Executives
Jiang Ru Dong	Securities Affairs Representative
Mao Wen Hua	Executives
Sun Yang	Director
Li Wei Jin	Director
Luo Yu Hong	Director
Pan Qing Hua	Directors, executives
Chen Zheng Hua	Supervisors
Jia Qiang	Executives, directors

Zhejiang Hisoar Pharmaceutical Co Headlines

No Headlines